suritozole has been researched along with scopolamine hydrobromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kane, JM; Moran, PM; Moser, PC | 1 |
| Dudchenko, P; Holley, LA; Sarter, M | 1 |
2 other study(ies) available for suritozole and scopolamine hydrobromide
| Article | Year |
|---|---|
Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Learning; Male; Memory; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values; Reinforcement, Psychology; Scopolamine; Triazoles | 1992 |
Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.
Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Male; Memory, Short-Term; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Scopolamine; Triazoles | 1992 |